A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine

被引：0
|
作者：
Kotoe Takayoshi
Kosuke Sagara
Keita Uchino
Hitoshi Kusaba
Naotaka Sakamoto
Atsushi Iguchi
Eishi Baba
机构：
[1] Clinical Research Institute,Department of Medical Oncology
[2] National Hospital Organization Kyushu Medical Center,Department of Medicine and Biosystemic Science
[3] Kyushu University Graduate School of Medical Sciences,Department of Urology
[4] National Hospital Organization Kyushu Medical Center,Department of Comprehensive Clinical Oncology
[5] Faculty of Medical Sciences,undefined
[6] Kyushu University,undefined
来源：
BMC Cancer | / 15卷
关键词：
ABCB1; Adverse event; Bile duct carcinoma; Gemcitabine; Plasma concentration; Renal cell carcinoma; Sunitinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Metastatic bile duct carcinoma: Tucatinib/trastuzumab combination tested
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (06):
  • [42] Phase I Study of Sunitinib in Combination With Gemcitabine and Capecitabine for First-Line Treatment of Metastatic or Unresectable Renal Cell Carcinoma
    Bellmunt, Joaquim
    Suarez, Cristina
    Gallardo, Enrique
    Rodon, Jordi
    Pons, Francesc
    Bonfill, Teresa
    Beltran, Marta
    Moya, Irene
    Galtes, Susana
    Albanell, Joan
    Carles, Joan
    ONCOLOGIST, 2014, 19 (09): : 917 - 918
  • [43] Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
    Nachbargauer, Sebastian
    Bruchbacher, Andreas
    Fajkovic, Harun
    Remzi, Mesut
    Schmidinger, Manuela
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : E277 - E283
  • [44] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Bajic, Petar
    Flanigan, Robert C.
    Joyce, Cara J.
    Clark, Joseph I.
    JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
  • [45] SUNITINIB RECHALLANGE IN METASTATIC RENAL CELL CARCINOMA PATIENTS
    Nagyivanyi, K.
    Biro, K.
    Gyergyay, F.
    Kueronya, Z.
    Nemeth, H.
    Geczi, L.
    ANNALS OF ONCOLOGY, 2012, 23 : 281 - 281
  • [46] Experience with sunitinib in the treatment of metastatic renal cell carcinoma
    Schmidinger, Manuela
    Larkin, James
    Ravaud, Alain
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 253 - 265
  • [47] Pazopanib or sunitinib for metastatic renal-cell carcinoma?
    Bennet, Neil
    LANCET ONCOLOGY, 2013, 14 (11): : E442 - E442
  • [48] Sunitinib (SUTENT®) for the treatment of metastatic renal cell carcinoma
    Hutson, Thomas E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (11) : 1723 - 1731
  • [49] Sunitinib Dose Escalation in Metastatic Renal Cell Carcinoma
    Bruchbacher, Andreas
    Nachbargauer, Sebastian
    Fajkovic, Harun
    Schmidinger, Manuela
    KIDNEY CANCER, 2019, 3 (02) : 103 - 110
  • [50] Sunitinib in advanced/metastatic renal cell carcinoma in adults
    Martin Vila, A.
    Alvarez Seoane, J.
    Perez Parente, D.
    Alvarez Payero, M.
    Ucha Samartin, M.
    Martinez Lopez de Castro, N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 239 - 239
12345